Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06539689
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-29
Brief Title:
A Trail of Sperstent Used for Residual Lesions of Femoropopliteal Arteries
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Prospective Multicenter and Randomized Controlled Trial to Evaluate the Efficacy and Safety of Sperstent Peripheral Spot Stent System Used for the Residual Lesions After Percutaneous Transluminal Angioplasty of Femoropopliteal Arteries
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SURF
Brief Summary:
This is a prospective multi-center randomized trial designed to investigate the efficacy and safety of Sperstent peripheral spot stent system versus Everflex self-expanding peripheral stent system in the endovascular treatment of post-balloon angioplasty post-PTA residual lesions including stenoses andor dissections in femoral and proximal popliteal arteries
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None